AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities ...
Use of hepatitis B vaccines in U.S. newborns was declining well before the Centers for Disease Control and Prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results